Home/Filings/4/0001209191-20-014467
4//SEC Filing

Mallon Mark 4

Accession 0001209191-20-014467

CIK 0001446847other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 4:29 PM ET

Size

4.8 KB

Accession

0001209191-20-014467

Insider Transaction Report

Form 4
Period: 2020-02-27
Mallon Mark
DirectorChief Executive Officer
Transactions
  • Award

    Class A Common Stock

    2020-02-27+221,061524,486 total
Footnotes (1)
  • [F1]The restricted stock unit award, granted as an annual performance award, vests as to approximately 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof.

Issuer

IRONWOOD PHARMACEUTICALS INC

CIK 0001446847

Entity typeother

Related Parties

1
  • filerCIK 0001763533

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:29 PM ET
Size
4.8 KB